Z-1909-2024 Class II Ongoing
FDA device recall Z-1909-2024 was initiated by Stryker Neurovascular on Apr 23, 2024 and is designated Class II. Reason for recall: Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may… The recall status is ongoing. Affected quantity: 2859.
Recall details
- Product Type
- Devices
- Report Date
- Jun 5, 2024
- Initiation Date
- Apr 23, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2859
Product description
Reason for recall
Distribution pattern
Worldwide - US Nationwide distribution including in the states of MN, PA, IL, AK, NY, CA, MI, WI, TX, AZ, FL, KY, MA, IN, NE, MT, CT, NJ, TN, VA, AL, CO, DE, OH, UT, NC, ME, GA, SC, GU, WA, MO, OR, DC, OK, LA, MD, ID, NH, SD, NV, RI, ND, HI, MS, AR, IA, NM, VT, KS and the countries of Australia, Austria, Belgium, Brazil, Canada, Canary Islands, Chile, China, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, SAR China, Hungary, India, Ireland, Israel, Italy, Japan, Korea (South), Lithuania, Luxembourg, Netherlands, Northern Ireland, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Singapore, Slovakia, Spain, Sweden, Switzerland, Taiwan, Republic of China, Thailand, Turkey, United Arab Emirates, United Kingdom.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1909-2024
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026